Search at Vanderbilt-Ingram Cancer Center

1046 results found

Avelumab or Hydroxychloroquine with or Without Palbociclib to Eliminate Dormant Breast Cancer

Relevance: 1

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

Relevance: 1

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

Relevance: 1

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

Relevance: 1

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study

Relevance: 1

Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

Relevance: 1

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

Relevance: 1

pBI-11 & TA-HPV (With Pembrolizumab as Treatment for Patients w/Advanced, PD-L1 CPS1, hrHPV+ Oropharyngeal Cancer

Relevance: 1

A Study of ASP3082 in Adults With Advanced Solid Tumors

Relevance: 1

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

Relevance: 1